Drug Regimen Review Conducted With Follow-Up for Identified Issues

Identifying Attributes

Care Settings
Care Transitions
Country
United States of America
Publishing Organisation
Centers for Medicare & Medicaid Services (CMS): Skilled Nursing Facility Quality Reporting Program
Type of Quality Indicator
Process
IOM Quality Dimension
Safety
Domain
Medication-Related

Defining Attributes

Definition

Percentage of resident stays in which a drug regimen review was conducted at the time of admission and timely follow-up with a physician occurred each time potential clinically significant medication issues were identified throughout that stay.

Numerator

Total number of denominator stays meeting each of the following 2 criteria: 1) The facility conducted a drug regimen review on admission and a) No potential and actual clinically significant medication issues were found during the review or b) potential or actual clinically significant medication issues were found during the review and then a physician(or physician- designee) was contacted and prescribed/recommended actions were complete by midnight of the next calendar day or c) the resident was not taking any medications. 2) Appropriate follow-up occurred each time a potential or actual clinically significant medication issue was identified during the stay; or no potential or actual clinically significant medication issues were identified since the admission or patient was not taking any medications.

Denominator

The number of Medicare Part A skilled nursing facility stays during the reporting period.

Exclusions

The resident died during the SNF stay (i.e. Type 2 SNF Stays).

Use of Risk Adjustment
No
Risk Adjustments

None

Stratifications

None

Data Attributes

Type of Data Collection
Standardised clinical data
Data Collection Methods

Collected using the Minimum Data Set (MDS) 3.0 Resident Assessment Instrument (RAI).

Frequency of Data Collection
Data are collected on admission, on discharge (planned and unplanned), and for expired patients. Measures are updated monthly, at the facility and resident level, as data become available. MDS is transmitted to the CMS quarterly via the Internet Quality Improvement Evaluation System (iQIES).
Frequency of Data Collection in Days
30
Reporting Methods

Skilled Nursing Facilities Quality Reporting Program (CMS and Providers). Certification and Survey Provider Enhanced Reports (CASPER) Review and Correct Reports contain facility-level and resident-level measure information CMS Care Compare - Nursing Homes and CMS Provider Compare (CMS, providers and publicly reported).

Reporting Frequency
Quarterly
Reporting Frequency in Days
91
Indicator Has Recommended Targets
No

Source and Reference Attributes

Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
12 March 2025